Kidney and Pancreas Transplant Market

Global Kidney and Pancreas Transplant Market Size, Share & Trends Analysis Report by Sources (Living Donors, and Deceased Donors) by Treatment ((Analgesic, Immunosuppressant, and Others) by End User (Hospitals, Transplant Centers, Others) Forecast 2022-2028

Published: May 2022 | Report Code: OMR2026597 | Category : Pharmaceuticals | Delivery Format: /

The global kidney and pancreas transplant market is anticipated to grow at a significant CAGR of 9.7% during the forecast period (2021-2028).  The factors that are responsible for the growth of the market are, high blood pressure and diabetes are the two most common causes of kidney failure. The kidney may also damage from physical injury, diseases, or other disorders. According to kidney.org in 2019, nearly 30% of patients with Type 1 diabetes and 10% to 40% of those with Type 2 diabetes eventually suffer from kidney failure.  As per the information provided by Organdonor.gov, nearly 40,000+ transplants were performed in 2021 globally, and 90,483 patients were on the waiting list.  Technological advancements and the availability of various treatments for kidney failure such as dialysis and kidney transplants enhance the growth of the market. 

Moreover, the Health Resources and Services Administration.gov, the transplants in the US by recipient gender in 2021 were 41,355, and in 2022 were 13,567. The easy availability of Living Donors, and Deceased Donors, in various healthcare centers such as hospitals, and medical centers, are expected to boost the market growth in the coming future. As per the same source, the total number of deceased donors in 2021 was were13, 863 and the total number of living donors was 6,593 in the US. Hence, the rising number of deceased and live donors and high number of kidney transplants performed, drive the growth of the global kidney and pancreas transplant market. 

Impact of COVID-19 Pandemic on Global Kidney and Pancreas Transplant Market 

COVID-19 shows a negative effect on the global kidney and pancreas transplant market.  Most transplant centers have implemented policies to obviate physical interaction between kidney transplant recipients with the public, and this policy is continued in the reopening phase.  Moreover, the kidney transplant recipients were at a higher risk of serious complications from COVID-19, due to the chronically immunosuppressed stage and a high prevalence of comorbidities such as diabetes, heart disease, and lung disease. Hence, the COVID-19 pandemic shows a negative impact on the kidney and pancreas transplants market.  

Segmental Outlook 

The global kidney and pancreas transplant market is segmented on the basis of sources, treatment, and end user. Based on sources, the market is sub-divided into living donors, deceased donors. Based on treatment, the market is bifurcated into analgesic, immunosuppressant, others. Based on end user, the market is sub-segmented into hospitals, transplant centers, others. Based on end user, the hospitals, segment is projected to reach at the highest rate; the people largely prefer hospitals than transplant clinics for treatments as hospitals have the availability of specialized healthcare professionals that can assist patients anytime they want. The hospital segment in the kidney and pancreases transplant market is anticipated to grow during the forecast period, owing to several factors such as a dependable treatment, availability of much experienced doctors, and others, are the major factors that boost the market growth. 

Global Kidney and Pancreas Transplant Market Share by Technology, 2021 (%)

Global Kidney and Pancreas Transplant Market Share by Technology

The Deceased Donor Segment is Prove to be The Fastest Growing Segment in Global Kidney and Transplant Market 

The deceased donor segment is anticipated to grow at a fast rate, owing to the rising number of kidney and pancreas transplant surgeries across the globe. Deceased donors are those donors that give their organs to needy ones, after their death. The increasing prevalence of diabetes results in a higher kidney-pancreas transplant thus leading to higher demand for the deceased donor in coming years. According to, the proportion of patients with type 2 diabetes continued to increase, reaching 17.0% in 2019, up from 14.2% in 2018, and the total number of deceased donors who donate a kidney for transplant, was 4,704 from January to April 2022. Moreover, According to, UNOS.org, in 2021 in the US the total number of deceased donors was 18,699, and in 2020, it was 18,410. This trend is likely to continue as the enthusiasm for performing kidney-pancreas transplants in candidates with type 2 diabetes continues to rise.

Regional Outlooks

The global kidney and pancreas transplant market is further segmented based on geography including North America (The US, and Canada Europe (Italy, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The North American region is expected to grow at the fastest rate, owing to the advanced healthcare infrastructure, and availability of experienced healthcare professionals in the region, which leads to support the growth of the market in the North American region. 

Global Kidney and Pancreas Transplant Market Growth, by Region 2021-2028

Global Kidney and Pancreas Transplant Market Growth, by Region

Asia Pacific is the accounted for the Major Market share in Global Kidney and Pancreas Transplant Market 

The Asia Pacific region dominated the global kidney and pancreas transplant market during the forecast period. The growth is mainly driven due to the rising prevalence of high blood pressure in the geriatric population, increasing consumption of alcohol, following an unhealthy diet, and increasing incidence of stone problems especially in women in the Asia Pacific region is expected to show considerable growth during the forecast period. According to the International Journal of Community Medicine and Public Health report published in April 2019, shows that in India, 12% of people are estimated to have urinary stones, out of this 50% may end up with a loss of kidneys or renal damage. Also, near 15% of the people of Northern, India affected from urinary stones. Hence, with the rising prevalence of various diseases, and increasing in the geriatric population, contributes in the growth of the market. 

Market Players Outlook

The major companies serving the global kidney and pancreas transplant market are, AbbVie Inc, Medtronic plc, Novartis AG, Pfizer Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Luminex, Organ Recovery Systems Inc., and Organogenesis, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2020, Paragonix Technologies Inc., announced a US FDA 510(k) clearance of the Paragonix SherpaPak pancreas transport system (PTS). This system is available to Pancreas transplant centers and organ procurement organizations. The Paragonix SherpaPak PTS will be highly impactful for both single-pancreas transplantations as well as for combined pancreas plus kidney transplantation.

The Report Covers

  • Market value data analysis of 2021 and forecast to 2028.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global kidney and pancreas transplant market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future. 
  • Analysis of market entry and market expansion strategies.
  • Competitive strategies by identifying ‘who-stands-where’ in the market.

1. Report Summary

Current Industry Analysis and Growth Potential Outlook

Impact of COVID-19 on the Global Kidney and Pancreas Transplant Market

Recovery Scenario Of Global Kidney and Pancreas Transplant Market 

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

1.2.2. BY Region

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight and Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

3. Competitive Landscape

3.1. Key Company Analysis

3.1.1. AbbVie Inc.

3.1.1.1. Overview

3.1.1.2. Financial Analysis 

3.1.1.3. SWOT Analysis

3.1.1.4. Recent Developments

3.1.2. Medtronic Plc 

3.1.2.1. Overview

3.1.2.2. Financial Analysis 

3.1.2.3. SWOT Analysis

3.1.2.4. Recent Developments

3.1.3. Novartis AG

3.1.3.1. Overview

3.1.3.2. Financial Analysis 

3.1.3.3. SWOT Analysis

3.1.3.4. Recent Developments

3.1.3.5. Recent Developments

3.1.4. Pfizer Inc.

3.1.4.1. Overview

3.1.4.2. Financial Analysis 

3.1.4.3. SWOT Analysis

3.1.4.4. Recent Developments

3.1.4.5. Recent Developments

3.1.5. Thermo Fisher Scientific Inc

3.1.5.1. Overview

3.1.5.2. Financial Analysis 

3.1.5.3. SWOT Analysis

3.1.5.4. Recent Developments

3.1.5.5. Recent Developments

3.2. Key Strategy Analysis

3.3. Impact of Covid-19 on Key Players

4. Market Segmentation

4.1. Global Kidney and Pancreas Transplant Market by Sources 

4.1.1. Living Donors

4.1.2. Deceased Donors

4.2. Global Kidney and Pancreas Transplant Market by Treatment 

4.2.1. Analgesic

4.2.2. Immunosuppressant

4.2.3. Others

4.3. Global Kidney and Pancreas Transplant Market by End User 

4.3.1. Hospitals

4.3.2. Transplant Centers

4.3.3. Others

5.    Regional Analysis

5.1. North America

5.1.1. United States

5.1.2. Canada

5.2. Europe

5.2.1. UK

5.2.2. Germany

5.2.3. Italy

5.2.4. Spain 

5.2.5. France

5.2.6. Rest of Europe 

5.3. Asia-Pacific

5.3.1. China

5.3.2. India

5.3.3. Japan

5.3.4. South Korea

5.3.5. Rest of Asia-Pacific 

5.4. Rest of the World

6. Company Profiles 

6.1. Arthrex GmbH

6.2. Bio-Rad

6.3. CareDx Inc

6.4. Dr. Franz Köhler Chemie GmbH

6.5. F. Hoffmann-La Roche Ltd. 

6.6. Luminex 

6.7. Organ Recovery Systems Inc. 

6.8. Organogenesis

6.9. Sanofi US

6.10. Stryker 

6.11. Teva Pharmaceutical Industries Ltd. 

6.12. Veloxis Pharmaceuticals 

1. GLOBAL KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY SOURCES, 2021-2028 ($ MILLION)

2. GLOBAL LIVING DONORS AVAILABLE IN KIDNEY AND PANCREASE TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

3. GLOBAL DECEASED DONORS AVAILABLE IN KIDNEY AND PANCREASE TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

4. GLOBAL KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)

5. GLOBAL ANALGESIC FOR KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

6. GLOBAL IMMUNOSUPPRESSANT FOR KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS, 2021-2028 ($ MILLION)

7. GLOBAL OTHER TREATMENT FOR KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS, 2021-2028 ($ MILLION)

8. GLOBAL KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)

9. GLOBAL HOSPITALS FOR KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS, 2021-2028 ($ MILLION)

10. GLOBAL TRASNPLANT CENTERS FOR KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS, 2021-2028 ($ MILLION)

11. GLOBAL OTHER FOR KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS, 2021-2028 ($ MILLION)

12. NORTH AMERICAN KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028($ MILLION)

13. NORTH AMERICAN KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY SOURCES,2021-2028($ MILLION)

14. NORTH AMERICAN KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028($ MILLION)

15. NORTH AMERICAN KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY END USER, 2021-2028($ MILLION)

16. EUROPEAN KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028($ MILLION)

17. EUROPEAN KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY SOURCES,2021-2028($ MILLION)

18. EUROPEAN KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028($ MILLION)

19. EUROPEAN KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY END USER, 2021-2028($ MILLION)

20. ASIA-PACIFIC KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028($ MILLION)

21. ASIA-PACIFIC KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY SOURCES,2021-2028($ MILLION)

22. ASIA-PACIFIC KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY TREATMENT,2021-2028($ MILLION)

23. ASIA-PACIFIC KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY END USER,2021-2028($ MILLION)

24. REST OF THE WORLD KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028($ MILLION)

25. REST OF THE WORLD KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY SOURCES,2021-2028($ MILLION)

26. REST OF THE WORLD KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY TREATMENT,2021-2028($ MILLION)

27. REST OF THE WORLD KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY END USER,2021-2028($ MILLION)

1. IMPACT OF COVID-19 ON GLOBAL KIDNEY AND PANCREAS TRANSPLANT MARKET, 2021-2028 ($ MILLION)

2. IMPACT OF COVID-19 ON GLOBAL KIDNEY AND PANCREAS TRANSPLANT MARKET BY SEGMENT, 2021-2028 ($ MILLION)

3. RECOVERY OF GLOBAL KIDNEY AND PANCREAS TRANSPLANT MARKET, 2021-2028(%)

4. GLOBAL KIDNEY AND PANCREAS TRANSPLANT MARKET SHARE BY SOURCES, 2021-2028(%)

5. GLOBAL LIVING DONORS AVAILABLE IN KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)

6. GLOBAL DECEASED DONORS AVAILABLE IN KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)

7. GLOBAL KIDNEY AND PANCREAS TRANSPLANT MARKET SHARE BY TREATMENT, 2021-2028(%)

8. GLOBAL ANALGESIC FOR KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)

9. GLOBAL IMMUNOSUPPRESSANT FOR KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)

10. GLOBAL OTHERS FOR KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)

11. GLOBAL KIDNEY AND PANCREAS TRANSPLANT MARKET SHARE BY END USER, 2021-2028(%)

12. GLOBAL HOSPITALS FOR KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)

13. GLOBAL TRANPLANT CENTERS FOR KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)

14. GLOBAL OTHERS FOR KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)

15. GLOBAL KIDNEY AND PANCREAS TRANSPLANT MARKET BY SHARE BY GEOGRAPHY, 2021 VS 2028 (%)

16. US KIDNEY AND PANCREAS TRANSPLANT MARKET SIZE, 2021-2028($ MILLION)

17. CANADA KIDNEY AND PANCREAS TRANSPLANT MARKET SIZE, 2021-2028($ MILLION)

18. UK KIDNEY AND PANCREAS TRANSPLANT MARKET SIZE, 2021-2028($ MILLION)

19. GERMANY KIDNEY AND PANCREAS TRANSPLANT MARKET SIZE, 2021-2028($ MILLION)

20. SPAIN KIDNEY AND PANCREAS TRANSPLANT MARKET SIZE, 2021-2028($ MILLION)

21. FRANCE KIDNEY AND PANCREAS TRANSPLANT MARKET SIZE, 2021-2028($ MILLION)

22. ITALY KIDNEY AND PANCREAS TRANSPLANT MARKET SIZE, 2021-2028($ MILLION)

23. REST OF EUROPE KIDNEY AND PANCREAS TRANSPLANT MARKET SIZE, 2021-2028($ MILLION)

24. INDIA KIDNEY AND PANCREAS TRANSPLANT MARKET SIZE, 2021-2028($ MILLION)

25. CHINA KIDNEY AND PANCREAS TRANSPLANT MARKET SIZE, 2021-2028($ MILLION)

26. JAPAN KIDNEY AND PANCREAS TRANSPLANT MARKET SIZE, 2021-2028($ MILLION)

27. REST OF ASIA-PACIFIC KIDNEY AND PANCREAS TRANSPLANT MARKET SIZE, 2021-2028($ MILLION)

28. REST OF WORLD KIDNEY AND PANCREAS TRANSPLANT MARKET SIZE, 2021-2028($ MILLION)